Language selection

Search

Patent 1323032 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1323032
(21) Application Number: 549936
(54) English Title: PROCESS FOR PREPARING 2-GUANIDINOTHIAZOLE DERIVATIVES
(54) French Title: PROCEDE POUR LA PREPARATION DE DERIVES 2-GUANIDINOTHIAZOLE
Status: Deemed expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/310.5
(51) International Patent Classification (IPC):
  • C07D 277/42 (2006.01)
  • A61K 31/41 (2006.01)
  • A61K 31/425 (2006.01)
  • C07D 277/00 (2006.01)
  • C07D 277/20 (2006.01)
  • C07D 277/48 (2006.01)
  • C07D 277/50 (2006.01)
  • C07D 277/18 (2006.01)
(72) Inventors :
  • BOGSCH, ERIK (Hungary)
  • TRISCHLER, FERENC (Hungary)
  • BOD, PETER (Hungary)
  • HARSANYI, KALMAN (Hungary)
  • CSONGOR, EVA AGAINE (Hungary)
(73) Owners :
  • RICHTER GEDEON VEGYESZETI GYAR RT. (Hungary)
(71) Applicants :
(74) Agent: G. RONALD BELL & ASSOCIATES
(74) Associate agent:
(45) Issued: 1993-10-12
(22) Filed Date: 1987-10-21
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
4658/86 Hungary 1986-11-12

Abstracts

English Abstract


Abstract
PROCESS FOR PREPARING 2-GUANIDINOTHIAZOLE DERIVATIVES

The invention relates to a process for preparing
2-guanidinothiazole derivatives of the general formula
(I)


Image (I)


wherein Y stands for the group of the formula (II)


Image (II)




or (III)
-CH2-CH2CN (III)

as well as their salts, which comprises
a) cyclizing amidinothiourea of the formula
(IV)

(IV)
Image

- 2 -
with an 1,3-dihaloacetone in a solvent preferably
in acetone and in the presence of an iodide
catalyst soluble in said solvent, preferably sodium iodide
and reacting, without isolation, the thus obtained halogen
derivative of the formula (V)

Image
(V)


wherein X represents halogen, with thiourea in the
presence of water, to give the compound of the formula
(I), wherein Y means the group of the formula (II),
b1) cyclizing amidinothiourea of the formula
(IV) with an 1,3-dihaloacetone in a solvent, preferably
in acetone and in the presence of an iodide catalyst
soluble in said solvent, preferably sodium iodide,
then reacting without isolation the thus obtained
halogen derivative of the formula (V), wherein X is
halogen, with thiourea in the presence of water and then
S-cyanoethylating with acrylonitrile in an alkaline
aqueous-alkanolic medium to give the compound of the
formula (I), wherein Y stands for the group of the formula
(III),
b2) S-cyanoethylating as starting substance
the compound of the formula (I), wherein Y means a group


- 3 -

of the formula (II), with acrylonitrile in an alkaline
aqueous-alkanolic medium to obtain the compound of the
formula (I), wherein Y means the group of the formula
(III).
The compounds of the invention are valuable
intermediates in the preparation of pharmaceutics of
antiulcer effectiveness.


Claims

Note: Claims are shown in the official language in which they were submitted.



THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:

1. A process for the production of 2-
guanidinothiazole derivatives of the general formula (I)
(I)
Image

wherein Y stands for the group of the formula (II)


Image (II)
or (III)
-CH2-CH2-CN (III)

as well as their salts, which comprises
cyclizing amidinothiourea of the formula (IV)


(IV)
Image

with a 1,3-dihaloacetone in a solvent and in the presence
of an iodide catalyst soluble in said solvent and reacting,

16


without isolation, the thus obtained halogen derivative of
the formula (V)

Image (V)

wherein X represents halogen, with thiourea in the presence
of water, to give the compound of the formula (I), wherein
Y means the group of the formula (II); or
cyclizing amidinothiourea of the formula (IV)
with an 1,3-dihaloacetone in a solvent and in the presence
of an iodide catalyst, soluble in said solvent,
then reacting without isolation with the thus
obtained halogen derivative of the formula (V), wherein X
is halogen, with thiourea in the presence of water and then
S-cyanoethylating with acrylonitrile in an alkaline
aqueous-alkanolic medium to give the compound of the
formula (I), wherein Y stands for the group of the formula
(III); or
S-cyanoethylating as starting substance the
compound of the formula (I), wherein Y means a group of the
formula (II), with acrylonitrile in an alkaline aqueous-
alkanolic medium to obtain the compound of the formula (I),
wherein Y means the group of the formula (III).

2. A process as claimed in claim 1, which
comprises using the iodide catalyst in an amount of 1 to 10
mole %.

17

Description

Note: Descriptions are shown in the official language in which they were submitted.


1323032

PROCESS FOR PREPARING 2-GUANIDINOTHIAZOLE DERIVATIVES

This invention relates to a new process for
preparing 2-guanidinothiazole derivatives of the
general formula (I)
~12N ~ N '~S--Y ( I)



wherein
Y stands for the group of the formula (II)
~NH2

~ NH (II)

or the group of the formula (III)
-CH2-CH2-CN (III)

and their salts.
These compounds are important intermediates
for the preparation of famotidine /chemically N-sulfamyl-
-3-(2-guanidinothiazol-4-ylmethylthio)propionamidineJ
which has been proved to be an outstanding drug in the
therapy of gastric and duodenal ulcers.
The compounds prepared according to the inven-
tion are known in the literature. Chronologically, the
nitrile of the formula (I) wherein Y stands for the group
A4157-67 SZ6/sM



.
,'

1323032
-- 2


of the formula (III) had first been prepared from the
aminonitrile of the formula (VIII)

N~S ~CN
\~
H?N S (VIII)



by a 4-step lengthy route in a moderate yield according
to the United States patent specification No. 4,283,408.
According to the authors of the European patent
specification No. ~7,274, the isothiourea of the formula :
(I), wherein Y means a group of the formula (II), was
obtained in a yield above 90 % by reacting a compound
of the formula (V)

H 2~ N ~--X
H2N ~S~ HX ( )



wherein X is halogen, with thiourea in alcohol.
A drawback of this process, however, consists
therein that the starting chloromethyl compound is an
allergenic agent which irritates the skin and the mucous
membranes.
The isothiourea obtained in the above manner
was reacted with 3-chloropropionitrile in the presence of




, ~ : . - .. . ~:
- .,, ~ ~ ,

~, ~ ,: .:
:: :- : ~
~: . ,, : :~ , ~. . . .

1 323032i
_ 3 _


sodium hydroxide in aqueous alcohol under cooling to
give the nitrile in 89.8 % yield. This process is
cumbrous, demanding much time and work as the product
has to be isolated by using extraction, azeotropic drying
and recrystallization from a solvent mixture.
The researchers of the Yamanouchi Co. tried to
eliminate the drawbacks of the above methods by
developing an other process disclosed in the European
patent ~ No. 128,736. Dichloroacetone was
condensed with amidinothiourea below O C for several
days to obtain the thiazoline of the formula (VI)


OH

~2N~N ~ HCI (VI)


in 96.4 % yield. The thus obtained thiazoline was heated
with thiourea in alcohol to give the compound of the
formula (I), wherein Ymezns the group of the formula (II),
in 75.0 % yield (B3.8 % as calculated for thiourea) which
in turn was transformed with 3-chloropropionitrile in
the presence of an aqueous alkali, in a mixture of iso-

propanol and water to give the nitrile of the formula (I)
wherein Y is a group of the formula (III) in 79.2 % yield.
Thus, the overall yiéld of the compound of the formula (I),




/~7~



- . ' .: , ',

: ` ' ''' ,. -' : .
- . . , :

l323a~2




wherein Y is the group of the formula (II) amounts to
72,3 % that of the compound of the formula (I), wherein
Y is the group of the formula (III), to 57.2 % as calculat-
ed for amidinothiourea.
The reaction of the thi~zoline of formula (VI)
with thiourea was carried out also in an aqueous medium.
The aqueous solution of the compound obtain~ in situ was
diluted with isopropanol and then transformed with 3-
-chloropropionitrile in the presence of sodium hydroxide
under cooling to obtain the nitrile compound of the formula
(I), wherein Y is the group of formula (III), in a yield
of 83.5 % as calculated for the thiazoline of the formula
(VI) and in a yield of 80.5 %, respectively, as calculated
for the starting dichloroacetone and amidinothiourea.
The most important disadvantage of the above method
appears therein that the technological procedure is
cumbrous and lengthy, the cyclization requires cooling
for the whole reaction period and the thus obtained
thiazoline compound of the formula (VI) is quite unstable.
According to our investigations, this thiazoline d~rivative
is very unstable at room temperature.
The intermediary skin-irritating chloromethyl
compound of the formula (V), wherein X means chlorine, was
for the first time described in the Belgian patent
specification No. B66,156 according to which dichloroacetone
was reacted with amidinothiourea by stirring in acetone
solution overnight at room temperature. However,


- 132~2

the yield of the pure chloromethyl compound obtained by
recrystallization from alcohol was not given. According
to our determinations, this yield is lower than ~O %.
Other methods of the preparation are not known in the
literature, or are equivalents to or variants of the
above process.
Thus, the aim of the present invention is to
provide a process wherein the intermediates of the general
formula (I) of famotidine can be prepared in a single
pot whereby the isolation of the other intermediary
products having inconvenient properties becomes unnecessary.
The invention is based on the recognition that the
S-alkylation carried out by reacting a dihaloacetone with
amidinothiourea of the formula (IV) - --

H2N NH2
H2 N J~ S (IV)


and the following cyclization can selectively be achieved
by using a iodide catalyst in a solvent medium to result
in the separation of the halomethyl compound of the
~eneral ~ormula (V) in a crystalline form from the
reaction mixture. After adding water and thiourea, this
compound can be transformed to one of the target products,
i.e. to the compound of the formula (I), wherein Y means




" . " " : " " ," " ~

-` 132333~


the group of the formula (II), which separates in a pure
crystalline state from the reaction mixture.
Further on, it has been recognized that the
isolation of all other intermediates can be eliminated
in the preparation of the compound of the formula (I),
wherein Y means a group of the formula (III). Thus after
diluting with water, removing the acetone and adding
alcohol, acrylonitrile and sodium hydroxide, the in
situ formed mercaptan compound of the formula (VII).



~ ~ S ~J ( V I I )

H2N N S

may be S-cyanoethylated easily in alkaline medium.
The thus-obtained nitrile product separates from the
reaction mixture in a crystalline form.
Novel and surprising elements are also involved
in the above recognition. Namely, it could not be expected -
that such a degree of selectivity would be achieved
both in the cyclization as well as in the S-alkylation
by using an iodide catalyst in an acetone medium. This
is well supported by the fact that without an iodide
catalyst in the reaction of dichloroacetone with amidino-
thiourea followed by the reaction with thiourea, the
yields obtained were by 25 to 35 % lower as compared
to the yield of the reaction based on our recognition
although the only difference consisted in the catalysis.




., , ., ' ! ' ' ' '
' J '~

:, ' ' ' ,' ' ~'.' ' ' ,' '.' .
'.' ' ~ ' . ' ' ' .~ ' ' ' ~ ' .
.

~323~2
-- 7




In addition, the selectivity-enhancing role of
the iodide catalysis was also verified in the case of
2-amino-4-chloromethylthiazole hydrochloride of the
formula (IX)



N - -.~CI (IX)
H N /~ 5 9 ~ HC I



a compound known from the literature. By reacting
thiourea with dichloroacetone in an 1:1 molar ratio,
the compound of the formula (IX) was obtained in 58.5 %
yield and the following reaction with thiourea resulted
in the compound of the formula (X)
~`~H2



~<~ ~ 2 HCI
H2~ S

in a yield of 22.2 % /J. Am. Chem. Soc. 68, 2156 (1946)/.
In contrast to these yields, the compound of the formula
(IX) was obtained in a yield of 86 % by using the
iodide catalysis recognized in our experiments.
It is also known that the cyclization of theco~xund of

formula (IV) involves at least three elemental steps.
As it can be expected that the first step~ i.e. the
S-alkylation is only accelerated by the iodide catalysis,

. ,,~


, ' '' . '


.
' ~ " ' ' , , . ' . ,
,

1323032
~- a-


it is also surprising that, in addition to the increase
in the selectivity, the whole thiazole formation is
accelerated.
Thus, the present invention relates to a new
process for preparing the 2-guanidinothiazole
derivatives of the general formula (I), wherein Y
stands for the group of the formula (II) or (III), as well
as their salts, which comprises
a) cyclizing amidinothiourea of the formula (IV)
with an l,3-dihaloacetone in a solvent preferably in
acetone and in the presence of an iodide
catalyst soluble in said solvent, preferably sodium iodide
and reacting, without isolation, the thus obtained
halogen derivative of the formula (V), wherein X represents
halogen, with thiourea in the presence of water, to give the
compound of the formula (I), wherein Y means the group
of the formula (II),
bl) cyclizing amidinothiourea of the formula
(IV) with an 1,3-dihaloacetone in a solvent, preferably
in acetone and in -~he presence OI an iodide ca-talyst
sol~ble in said solvent, preferably scdi.um iodide,
then reacting without isolation the thus obtained
halogen derivative of the formula (V), wherein X is
halogen, with thiourea in the presence of water and then
S-cyanoethylating with acrylonitrile in an alkaline aqueous-
-alkanolic medium to give the compound of the formula (I),




:, ~ , , ; . , , . : :

1323032


wherein Y stands for the group of the formula (III),
b2) S-cyanoethylating as starting substance
the compound of the formula (I), wherein Y means a group
of the formula (II), with acrylonitrile in an alkaline
aqueous-alkanolic medium to obtain the compound of the
formula (I), wherein Y means the group of the formula
(III).
Accordlng to a preferred embodiment of the
process of the invention, the iodide catalyst is used
in an amount of 1 to 10 mole%, preferably 4 to 6 mole~A
In the process of the invention, the compound of
the formula (I) wherein Y means a group of the formula
(II) is formed at a tempe~ture between 20 C and 60 C
and the thus obtained compound is S-cyanoethylated at
a pH value of 11 to 13, at a temperature between 20 C



In the process of the invention, amidinothiourea

of the formula (IV) is portionwise added to the appropriate
preferably of dichloroacetone/
dihaloaceton~/in a solvent, preferably in acetone also
containing sodium iodide. Water and thiourea are added
to the thus formed crystal suspension and after boiling
and cooling, the thus obtained compound of the formula (I),
wherein Y stands for the group of the formula (II), is
filtered, washed with aqueous acetone and dried.
When the aim is to obtain the nitrile, i.e. the
compound of the formula (I), wherein Y is the group of
the formula (III), then during the boiling with thiourea




- -, - -

1323~32
- 10 -

in water, acetone is continuously distilled out from
the reaction mixture simultneously with the portionwise
addition of water. The thus resulting aqueous solution is
cooled, diluted with alcohol and then, the desired amount
of acrylonitrile and aqueous sodium hydroxide solution
are added. The thus formed nitrile is filtered, washed
and dried.
The advantages of the process of the invention can
be summarized as follows.
a) Owing to the iodide catalysis, the carrying
out of a cyclization lasting for several days below O C
as well as the isolation of the unstable intermediates
become unnecessary.
b) The obtained skin-irritating product of the
formula (V) can further be transformed without isolation
in the same pot.
c) The solvent system used provides the separa-
tion of the compounds of the formula (I) and their salts
in a pure state whilst the contaminations remain in the
mother liquor.
d) For preparing the nitrile, the much more
simply available and cheaper acrylonitrile can be used
instead of 3-chloropropionitrile described in the
literature.
e) By using the process of the invention, the
compound of the formula (I), wherein Y is a group of
the formula (III), can ~also be prepared from the iso-




- , , ~; , , :.,, :,~i


: ~
,. . . . ... .

~32~

thiourea derivative of the formula (I), wherein Y is a
group of the formula (II) formed in situ.
f) Due to the low worktime input and the excellent
yields, the process of the invention is extremely
useful for the industri~ realization The volume utiliza-
tion is also very advantageous: 240 kg of the compound
of the formula (I), wherein Y is a group of the formula
(II), or 100 to 160 kg of that, wherein Y is a group of
the formula (III), can be prepared in a working volume
of 1 m3.
The process of the invention is illustrated in
detail by the following non-limiting Examples~
Example 1
Preparation of 5-(2-guanidinothiazol-4-yl-
methyl)isothiourea dihydrochloride monohydrate /compound
of the formula (I), wherein Y is the group of the formula
(II)/
Example 1.1
11.8 9 (0.1 mole) of amidinothiourea are added to a
stirred solution containing 12.7 9 (0.1 mole) of 1,3-di-
chloroacetone and 0.75 9 (0.005 mole) of sodium iodide in 92
ml of acetone during 2 hours. After stirring for additional
2 hours, 9.2 9 of water are added and a solution is
formed after boiling for a short time. To this solution,
7.6 9 (0.1 mole) of thiourea are added whereupon the mixture
is boiled for one hour. The reaction mixture containing




.: . . . .
, : . - . ~
.: , .. '

1323~32
- 12 -



the oily reaction product is allowed to cool while
stirring. The thus formed crystal suspension is cooled
at 0 C, then filtered, washed twice with acetone and
dried to give the title product, m.p.: 209-213 C (with
decomp.), in a yield of 27.86 9 (85 %) with an active
ingredient content of 98 % as determined by potentio-
metric titration.
Example 1.2
35,4 9 (0.3 mole) of amidinothiourea are
portionwise added to a stirred solution containing 36.1
9 (0.3 mole) of 1,3-dichloroacetone and 2.25 9 (0.015
mole) of sodium iodide in 240 ml of acetone at 30 to 36 C
during one hour. The thus obtained crystal suspension is
stirred at the same temperature for one additional hour
and, after adding 30 ml of water and 24 9 (0.315 mole)
of thiourea, the mixture is refluxed while stirring for
one hour. The mixture is allowed to cool to room temperature,
the crystalline product is filtered and washed twice
with 40 ml of 90 % acetone each to give the title product,
m.p.: 210-214 C (with decom.), in a yield of 88.02 9
(89.7 %) with an active ingredient content of 98.2 %
as determined by potentiometric titration.
Example 1.3
127.0 kg (500 moles) of 1,3-dichloroacetone in
a 50 weight% acetonic solution are pumped into a reactor
of 1000 litres. After adding 257 kg of acetone and 3.75 kg
(25 moles) of sodium iodide, 60.5 kg of amidinothiourea




.. ~
-
:
: : , : ,: -
: - ~- : : :.
-
: -
~:. . - ~. . ~ ,.

1323~
- 13 -



of 97.6 % purity (500 moles) are portionwise added to
the reaction mixture during 1.0 to 1.5 hours under
stirring. The desired inner temperature of 30 to 40 C
is maintained by flowing cold industrial water in the
jacket. After stirring the reaction mixture for one
additional hour, 50 litres of water and 41.2 kg of thio-
urea of 97 % purity (525 moles) are added and the mixture
is boiled under stirring for one hour. Then, the
temperature of the reaction mixture is smoothly cooled
to room temperature within 2 to 3 hours, the suspension is
centrifuged, the product is washed in the centrifuge with
an 8:1 mixture of acetone and water and dried to give the
title product, m.p.: 209-214 C (with decom.) in a yield
of 148.3 kg (90.0%) with an active ingredient content
of 97.5 %.
Example 2
Preparation of 3-(2-guanidinothiazol-4-ylmethyl-
thio)propionitrile /compound of the formula (I), wherein
Y is the group of the formula (III)/
Example 2.1
20 ml of 10 N sodium hydroxide solution (of
40 ~) are portionwise added to a solution containing
32.7B g (0.1 mole of 98%) of S-(2-guanidinothiazol-4-
-ylmethyl)isothiourea dihydrochloride monohydrate (as
prepared in Examples 1.1, 1.2 or 1.3) and B.0 9 (0.15 mole)
of acrylonitrile in 100 ml of water and 40 ml of isopropanol.
After stirring for 2 hours, 30 ml of water are added and
after cooling by ice the precipitated product is filtered,




,, ,, . "
" ' :: . ' ~ ' . ' . "' .
'' ~ '

-` 132303~
- 14 -

washed with water, then with isopropanol and dried to
give the title product, m.p.: 127-129 C in a yield
of 22 9 (91 %) with an active ingredient content of
99.0 % as determined by potentiometric titration with
hydrochloric acid.
Example 2.2
65.8 9 (0.20 mole) of the product prepared
according to Example 1.1 are mixed with 16 9 (0.30 mole)
of acrylonitrile, 80 ml of water and 60 ml of alcohol.
After adding 43 ml (0.43 mole) of 10 N sodium hydroxide
solution, the mixture is stirred for 2 hours, filtered at
15 to 20 C, washed with water and then withalcohol and
dried to give the title product in a yield of 45.4 9
(94 %), m.p.: 127-128.5 C, with an active ingredient
content of 99.1 % as determined by titration. -
Example 2.3
A solution of 3~.1 9 of 1,3-dichloroacetone and
2.25 9 of sodium iodide in 240 ml of acetone is
treated with 35,4 9 of amidinothiourea under stirring
as described in Example 1.2. After adding 120 ml of water
and 24 9 of thiourea, 220 ml of acetone are distilled
from the reaction mixture. To the residue cooled down 90
ml of ethanol, 24 9 of acrylonitrile and 63 ml of 10 N
sodium hydroxide solution are poured. After stirring
for additional 2 hours and cooling below 20 C, the mixture
is filtered, the precipitate is washed with water, then

1323~32


with alcohol and dried to give the title product, m.p.:
127-128 C, in a yield of 62.1 9 (~4.~ %) with an active
ingredient content of 98.9 %.




: ^ ''

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1993-10-12
(22) Filed 1987-10-21
(45) Issued 1993-10-12
Deemed Expired 2007-10-12

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1987-10-21
Registration of a document - section 124 $0.00 1990-06-29
Maintenance Fee - Patent - Old Act 2 1995-10-12 $100.00 1995-09-28
Maintenance Fee - Patent - Old Act 3 1996-10-14 $100.00 1996-09-27
Maintenance Fee - Patent - Old Act 4 1997-10-14 $100.00 1997-09-26
Maintenance Fee - Patent - Old Act 5 1998-10-13 $150.00 1998-09-24
Maintenance Fee - Patent - Old Act 6 1999-10-12 $150.00 1999-09-29
Maintenance Fee - Patent - Old Act 7 2000-10-12 $150.00 2000-09-21
Maintenance Fee - Patent - Old Act 8 2001-10-12 $150.00 2001-09-18
Maintenance Fee - Patent - Old Act 9 2002-10-14 $150.00 2002-09-18
Maintenance Fee - Patent - Old Act 10 2003-10-13 $200.00 2003-09-19
Maintenance Fee - Patent - Old Act 11 2004-10-12 $250.00 2004-09-21
Maintenance Fee - Patent - Old Act 12 2005-10-12 $250.00 2005-09-27
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
RICHTER GEDEON VEGYESZETI GYAR RT.
Past Owners on Record
BOD, PETER
BOGSCH, ERIK
CSONGOR, EVA AGAINE
HARSANYI, KALMAN
TRISCHLER, FERENC
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative Drawing 2001-08-20 1 3
Drawings 1994-03-08 1 23
Claims 1994-03-08 2 55
Abstract 1994-03-08 3 54
Cover Page 1994-03-08 1 30
Description 1994-03-08 15 429
Fees 2000-09-21 1 45
Fees 1998-09-24 1 48
Fees 1997-09-26 1 53
Fees 1999-09-29 1 46
Office Letter 1988-03-10 1 14
PCT Correspondence 1993-07-16 1 23
PCT Correspondence 1988-02-05 1 26
PCT Correspondence 1988-03-04 1 26
Prosecution Correspondence 1991-12-12 2 60
Prosecution Correspondence 1990-09-10 2 60
Examiner Requisition 1991-09-05 1 44
Examiner Requisition 1990-06-20 1 62
Fees 1996-09-27 1 50
Fees 1995-09-28 1 33